Skip to content

Clinical trials

Phase 1 Lymphoma, T-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Phase: Phase 1 Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20203
20216
20223
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10
Completed2
Terminated2
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
iCell Gene Therapeutics3
Beijing Boren Hospital2
BGI, China1
Corvus Pharmaceuticals, Inc.1
Fundamenta Therapeutics, Ltd.1
Hebei Senlang Biotechnology Inc., Ltd.1
Institute of Hematology & Blood Diseases Hospital, China1
Lanzhou Institute of Biological Products Co., Ltd1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell17
Leukemia, T-Cell7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma6
Lymphoma3
Immunoblastic Lymphadenopathy2
Leukemia2
Leukemia, Myeloid, Acute2
Lymphoma, Large-Cell, Anaplastic2
Epstein-Barr Virus Infections1
Hodgkin Disease1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.